April 15, 2014 / 5:06 PM / 3 years ago

BRIEF-GSK receives US approval for diabetes treatment Tanzeum

1 Min Read

April 15 (Reuters) - Glaxosmithkline Plc

* Tanzeum (Albiglutide) receives FDA approval

* GSK receives US approval for once-weekly type 2 diabetes treatment, Tanzeum Tm (Albiglutide)

* Following this approval by FDA, GSK anticipates US launch of Tanzeum in Q3 of 2014 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below